6[4]Barker JN.Pathogcnesis of psorlasis[J].Dcrmatol,1998,25:778-781.
7[5]Austin LM,Ozawa M,Kikuehi T,et al.The majority of epidermal T cell in Psoriasis vulgaris lesions can produce type Ⅰ eytokines,in-terferon-gamma,interlenkin-2,and tumor necrosis factor alpha,defining TCL (cytotoxic T lymphocyte) and Thl effector populations;a type 1 differentiation bias is also measured in eirenlating blood T cells in psoriatic patients[J].Invest Dermatol,1999,113:752-759.
8[11]Van de Kerkhof PC.The psoriasis area and severity index and alter-native approaches for the assessment of severity:persisting areas of confusion[J].Br J Dcrmatol,1997,137:661-662.
9[13]Battaglia M,Gianfranl C,Gregod S,et al.IL-10 producing T regula-tory type 1 cells and oral tolerance[J].Ann N Y Acad Sei USA,2004,1029:142-153.
